Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Paul Rychwalski, MD

216.444.2030

Paul Rychwalski, MD
Department: Executive Administration, CCAD
Location: Abu Dhabi
Mail Code I32

UAE, Abu Dhabi,
WorkAppointment:216.444.2030
DeskDesk:216.444.2030
Paul Rychwalski, MD
Department: Ophthalmology
Location: Abu Dhabi
Mail Code I32

UAE, Abu Dhabi,
WorkAppointment:216.444.2030
DeskDesk:216.444.2030
Paul Rychwalski, MD
Department: Ophthalmology
Associate Staff
Location: Abu Dhabi
Mail Code I32

UAE, Abu Dhabi,
WorkAppointment:216.444.2030
DeskDesk:216.444.2030
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Paul J. Rychwalski, MD, is a full-time staff member with Cleveland Clinic Children’s Hospital Department of Ophthalmology and Cole Eye Institute. He sees patients at Main Campus and at Cole Eye Institute’s Beachwood location. In addition to his clinical appointment, Dr. Rychwalski is also an Associate Professor at Case Western Reserve School of Medicine, Lerner College of Medicine

Dr. Rychwalski is board certified in ophthalmology. He completed his undergraduate degree in biology and chemistry at University of Utah in Salt Lake City, and he earned his medical degree from Medical College of Wisconsin in Milwaukee. His post-graduate training includes an ophthalmology residency at Saint Louis University School of Medicine and Saint Louis University Hospital, as well as a pediatric ophthalmology and adult strabismus Fellowship at University of Kentucky Chandler Medical Center in Lexington.

Dr. Rychwalski is a member of several professional organizations. He is a Fellow of the American Academy of Ophthalmology and the American Academy of Pediatrics. He is also a member of the American Association for Pediatric Ophthalmology and Strabismus and the Association for Research in Vision and Ophthalmology, among others.

Dr. Rychwalski has been recognized as one of America’s Top Ophthalmologists by Consumer’s Research Council of America, and he has been named in “Best Doctors in America” since 2005 by the online resource Best Doctors, Inc. In addition, Dr. Rychwalski has volunteered his time to serve on medical missions to Gansu Providence, China, Columbia, and Romania. He also has served as Medical Advisor for the Cleveland Sight Center and as Medical Advisor to the Board of Directors for the Visually Impaired Pre-school Services, among other outreach activities.

Dr. Rychwalski has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts and presentations at a number of professional association meetings.

His specialty interests include childhood and adult strabismus, pediatric cataract and IOL placement, pediatric glaucoma and retinopathy of prematurity (ROP). He is fluent in English and Spanish.

Education & Fellowships

Fellowship - University of Kentucky Chandler Medical Center
Pediatric/Adult Strabismus
Lexington, KY USA
1998
Residency - St. Louis University Hospital
Ophthalmology
St. Louis, MO USA
1997
Internship - Gundersen Lutheran Medical Center
Medicine
La Crosse, WI USA
1994
Medical School - Medical College of Wisconsin
Milwaukee, WI USA
1993
Undergraduate - University of Utah
Salt Lake City, UT USA
1988

Certifications

  • Ophthalmology

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/22/2012, Dr. Rychwalski has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Spanish